University of Michigan–Ann Arbor-ko ikertzaileekin lankidetzan egindako argitalpenak (9)

2019

  1. Efficacy and safety during extended treatment of lesinurad in combination with febuxostat in patients with tophaceous gout: CRYSTAL extension study

    Arthritis Research and Therapy, Vol. 21, Núm. 1

  2. Gout

    Nature Reviews Disease Primers, Vol. 5, Núm. 1

  3. Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout

    Annals of the Rheumatic Diseases, Vol. 78, Núm. 11, pp. 1592-1600

2017

  1. Lesinurad, a Selective Uric Acid Reabsorption Inhibitor, in Combination With Febuxostat in Patients With Tophaceous Gout: Findings of a Phase III Clinical Trial

    Arthritis and Rheumatology, Vol. 69, Núm. 9, pp. 1903-1913

2016

  1. Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises

    Arthritis Care and Research, Vol. 68, Núm. 5, pp. 667-672

2015

  1. Imaging as an outcome measure in gout studies: Report from the OMERACT gout working group

    Journal of Rheumatology, Vol. 42, Núm. 12, pp. 2460-2464

2014

  1. Health related quality of life measure in systemic pediatric rheumatic diseases and its translation to different languages: An international collaboration

    Pediatric Rheumatology, Vol. 12, Núm. 1

2012

  1. 2012 American college of rheumatology guidelines for management of gout. part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia

    Arthritis Care and Research, Vol. 64, Núm. 10, pp. 1431-1446

  2. 2012 American college of rheumatology guidelines for management of gout. part 2: Therapy and antiinflammatory prophylaxis of acute gouty arthritis

    Arthritis Care and Research, Vol. 64, Núm. 10, pp. 1447-1461